Allogeneic Peripheral Blood Stem Cell Transplantation is a Promising and Safe Choice for the Treatment of Refractory/Relapsed Acute Myelogenous Leukemia, Even with a Higher Leukemia Burden-Reference-Cited by-同舟云学术

Allogeneic Peripheral Blood Stem Cell Transplantation is a Promising and Safe Choice for the Treatment of Refractory/Relapsed Acute Myelogenous Leukemia, Even with a Higher Leukemia Burden

Published:2013-04 Issue:4 Volume:19 Page:653-660
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Zhang Wei-Ping,Yang Dan,Song Xian-Min,Ni Xiong,Chen Jie,Chen Li,Yang Jian-min,Zhou Hong,Cheng Hui,Liu Bao-hai,Li Hong-Mei,Wang Jian-Min

Funder

National Natural Science Foundation of China

Foundation of Science and Technology Commission of Shanghai Municipality

“1255” Discipline Promotion Program of Changhai Hospital

Key Discipline Promotion Program of the Second Military Medical University

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference53 articles.

1. Outcome for children with relapsed acute myeloid leukemia in the Netherlands following initial treatment between 1980 and 1998: survival after chemotherapy only?;Goemans;Haematologica,2008

2. Outcome for children treated for relapsed or refractory acute myelogenous leukemia (rAML): a Therapeutic Advances in Childhood Leukemia (TACL) Consortium study;Gorman;Pediatr Blood Cancer,2010

3. Potential cure of acute myeloid leukemia: analysis of 1069 consecutive patients in first complete remission;Yanada;Cancer,2007

4. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up;Oyekunle;Bone Marrow Transplant,2006

5. Prognostic factors and therapeutic potions for relapsed or refractory acute myeloid leukemia;Ferrara;Haematologica,2004

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum cytokine profiles during engraftment syndrome and acute graft-versus-host disease in adult patients after hematopoietic stem cell transplantation;Cytokine;2024-06

2. Effect of sustained measurable residue disease negativity and post‐remission treatment selection on the prognosis of acute lymphoblastic leukemia in adults;Cancer Medicine;2024-05

3. Comparison of Stem Cell Transplantation Using Unrelated, Haploidentical, and Sibling Donors for Patients with Acquired Severe Aplastic Anemia: A Single-Center Retrospective Cohort Study;Transplantation and Cellular Therapy;2024-02

4. Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study;Annals of Hematology;2023-09-08

5. Cytogenetic abnormalities in NPM1-mutated acute myeloid leukemia;Leukemia & Lymphoma;2022-02-28